| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 730007 | 85652 | VANCOMICINA NORMON 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | VANCOMICINA NORMON 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85652/85652_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85652/85652_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2020-12-15 | 1 | 1 | 1 | 2020-12-16 | 2020-12-15 | 0 | 2021-03-12 | View Edit Delete | ||||||||||||
| 730110 | 85690 | BUSULFANO GLENMARK 6 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | BUSULFANO GLENMARK 6 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 8 viales de 10 ml | 60 mg inyectable 10 ml | 45 | 8 | 34 | 8 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85690/85690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85690/85690_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2021-01-14 | 1 | 1 | 1 | 2021-01-15 | 2021-01-14 | 0 | 2023-09-14 | View Edit Delete | ||||||||||||
| 730421 | 59621 | PENTACARINAT 300 MG POLVO PARA SOLUCION INYECTABLE | PENTACARINAT 300 MG POLVO PARA SOLUCION INYECTABLE,1 vial | 300 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59621/59621_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59621/59621_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 36616 | THE SIMPLE PHARMA COMPANY LIMITED | 1993-04-01 | 1 | 1 | 1 | 1993-04-01 | 2021-02-17 | 0 | 2022-06-09 | View Edit Delete | ||||||||||||
| 729667 | 1181322002IP | IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 2,4 ml | 50 mg/ml inyectable 2,4 ml | 45 | 1 | 34 | 1 vial de 2,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181322002IP/1181322002IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181322002IP/1181322002IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41484 | ABACUS MEDICINE A/S | 2020-11-03 | 1 | 1 | 1 | 2020-11-04 | 2020-11-03 | 0 | 2021-03-05 | View Edit Delete | ||||||||||||
| 729668 | 1181322001IP | IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 50 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181322001IP/1181322001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181322001IP/1181322001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41484 | ABACUS MEDICINE A/S | 2020-11-03 | 1 | 1 | 1 | 2020-11-04 | 2020-11-03 | 0 | 2021-03-05 | View Edit Delete | ||||||||||||
| 730079 | 114937001IP | GAZYVARO 1000 mg CONCENTRADO PARA SOLUCION PARA PERFUSION | GAZYVARO 1000 mg CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 40 ml | 1.000 mg inyectable 40 ml | 45 | 1 | 34 | 1 vial de 40 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114937001IP/114937001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114937001IP/114937001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ABACUS MEDICINE A/S | 2021-01-08 | 1 | 1 | 1 | 2021-01-09 | 2021-01-08 | 0 | 2021-03-23 | View Edit Delete | ||||||||||||
| 729201 | 67161 | OXIGENO MEDICINAL LIQUIDO NIPPON GASES 99,5% v/v, GAS CRIOGENICO MEDICINAL EN RECIPIENTE CRIOGENICO FIJO | OXIGENO MEDICINAL LIQUIDO NIPPON GASES 99,5% v/v, GAS CRIOGENICO MEDICINAL EN RECIPIENTE CRIOGENICO FIJO, 1 recipiente criogénico fijo de 13.600 l | 99,5% v/v | 94 | 13.600 | 25 | 1 recipiente criogénico fijo de 13.600 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67161/67161_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67161/67161_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 72974 | NIPPON GASES ESPANA SLU | 2005-11-04 | 1 | 1 | 1 | 2005-11-04 | 2020-09-03 | 0 | 2022-10-03 | View Edit Delete | ||||||||||||
| 730918 | 67553 | CLORURO DE SODIO FRESENIUS KABI 5,84% SOLUCION INYECTABLE | CLORURO DE SODIO FRESENIUS KABI 5,84% SOLUCION INYECTABLE,20 ampollas de 10 ml | 5,84% | 1 | 20 | 1 | 20 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67553/67553_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67553/67553_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2006-02-22 | 1 | 1 | 1 | 2006-02-22 | 2021-04-26 | 0 | 2021-08-02 | View Edit Delete | ||||||||||||
| 731342 | 86087 | CISATRACURIO KALCEKS 2 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | CISATRACURIO KALCEKS 2 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG, 5 ampollas de 5 ml | 2 mg/ml inyectable 5 ml | 1 | 5 | 1 | 5 ampollas de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86087/86087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86087/86087_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31754 | EVER PHARMA THERAPEUTICS SPAIN S.L. | 2021-10-05 | 1 | 1 | 1 | 2021-10-05 | 2021-10-05 | 0 | 2024-02-05 | View Edit Delete | ||||||||||||
| 731343 | 86087 | CISATRACURIO KALCEKS 2 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | CISATRACURIO KALCEKS 2 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG, 5 ampollas de 10 ml | 2 mg/ml inyectable 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86087/86087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86087/86087_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31754 | EVER PHARMA THERAPEUTICS SPAIN S.L. | 2021-10-05 | 1 | 1 | 1 | 2021-10-05 | 2021-10-05 | 0 | 2022-08-09 | View Edit Delete | ||||||||||||
| 730914 | 34369 | GLUCOSADA GRIFOLS 5% SOLUCION PARA PERFUSION | GLUCOSADA GRIFOLS 5% SOLUCION PARA PERFUSION, 115 bolsas de 100 ml conteniendo 50 ml (FLEBOFLEX) | 5% | 3 | 115 | 65 | 115 bolsas de 100 ml conteniendo 50 ml (FLEBOFLEX) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/34369/34369_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/34369/34369_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1234 | LABORATORIOS GRIFOLS S.A. | 1960-09-01 | 1 | 1 | 1 | 1960-09-01 | 2021-04-22 | 0 | 2022-07-11 | View Edit Delete | ||||||||||||
| 730915 | 34369 | GLUCOSADA GRIFOLS 5% SOLUCION PARA PERFUSION | GLUCOSADA GRIFOLS 5% SOLUCION PARA PERFUSION, 70 bolsas de 100 ml (FLEBOFLEX) | 5% | 3 | 70 | 65 | 70 bolsas de 100 ml (FLEBOFLEX) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/34369/34369_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/34369/34369_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1234 | LABORATORIOS GRIFOLS S.A. | 1960-09-01 | 1 | 1 | 1 | 1960-09-01 | 2021-04-22 | 0 | 2022-07-11 | View Edit Delete | ||||||||||||
| 730916 | 34369 | GLUCOSADA GRIFOLS 5% SOLUCION PARA PERFUSION | GLUCOSADA GRIFOLS 5% SOLUCION PARA PERFUSION, 28 bolsas de 250 ml (FLEBOFLEX) | 5% | 3 | 28 | 65 | 28 bolsas de 250 ml (FLEBOFLEX) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/34369/34369_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/34369/34369_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1234 | LABORATORIOS GRIFOLS S.A. | 1960-09-01 | 1 | 1 | 1 | 1960-09-01 | 2021-04-22 | 0 | 2022-07-11 | View Edit Delete | ||||||||||||
| 730917 | 34372 | GLUCOSALINA GRIFOLS SOLUCION PARA PERFUSION | GLUCOSALINA GRIFOLS SOLUCION PARA PERFUSION,28 bolsas de 250 ml (FLEBOFLEX) | 3,3% + 0,3% | 3 | 28 | 65 | 28 bolsas de 250 ml (FLEBOFLEX) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/34372/34372_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/34372/34372_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1234 | LABORATORIOS GRIFOLS S.A. | 1960-09-01 | 1 | 1 | 1 | 1960-09-01 | 2021-04-22 | 0 | 2022-07-11 | View Edit Delete | ||||||||||||
| 731000 | 85962 | LACOSAMIDA TARBIS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA TARBIS 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 100 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85962/85962_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85962/85962_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2021-05-12 | 1 | 1 | 1 | 2021-05-13 | 2021-05-12 | 0 | 2023-04-10 | View Edit Delete | ||||||||||||
| 731001 | 85963 | LACOSAMIDA TARBIS 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA TARBIS 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 150 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85963/85963_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85963/85963_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2021-05-12 | 1 | 1 | 1 | 2021-05-13 | 2021-05-12 | 0 | 2023-04-10 | View Edit Delete | ||||||||||||
| 731002 | 85964 | LACOSAMIDA TARBIS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA TARBIS 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 200 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85964/85964_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85964/85964_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2021-05-12 | 1 | 1 | 1 | 2021-05-13 | 2021-05-12 | 0 | 2023-04-10 | View Edit Delete | ||||||||||||
| 731003 | 85965 | LACOSAMIDA TARBIS 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA TARBIS 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 14 comprimidos | 50 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85965/85965_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85965/85965_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2021-05-12 | 1 | 1 | 1 | 2021-05-13 | 2021-05-12 | 0 | 2023-04-10 | View Edit Delete | ||||||||||||
| 731576 | 86182 | ENDOLEX 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ENDOLEX 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 12 comprimidos (PA/Al/PVC/Al) | 25 mg | 5 | 12 | 10 | 12 comprimidos (PA/Al/PVC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86182/86182_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86182/86182_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2021-09-03 | 1 | 1 | 1 | 2021-09-04 | 2021-09-03 | 0 | 2022-01-25 | View Edit Delete | ||||||||||||
| 731597 | 86184 | VALOTENSIX 10 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALOTENSIX 10 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86184/86184_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86184/86184_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2021-09-06 | 1 | 1 | 1 | 2021-09-07 | 2021-09-06 | 0 | 2021-11-19 | View Edit Delete |
Page 148 of 1036, showing 20 records out of 20709 total, starting on record 2941, ending on 2960